BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: MacPherson P, Houben RM, Glynn JR, Corbett EL, Kranzer K. Pre-treatment loss to follow-up in tuberculosis patients in low- and lower-middle-income countries and high-burden countries: a systematic review and meta-analysis. Bull World Health Organ 2014;92:126-38. [PMID: 24623906 DOI: 10.2471/BLT.13.124800] [Cited by in Crossref: 112] [Cited by in F6Publishing: 96] [Article Influence: 12.4] [Reference Citation Analysis]
Number Citing Articles
1 Haldane V, Zhang Z, Ma Q, Yin T, Zhang B, Li Y, Pan Q, Dainty KN, Rea E, Pasang P, Wei X, Hu J. A qualitative study of perspectives on access to tuberculosis health services in Xigaze, China. Infect Dis Poverty 2021;10:120. [PMID: 34544492 DOI: 10.1186/s40249-021-00906-4] [Reference Citation Analysis]
2 Mwansa-Kambafwile JRM, Chasela C, Ismail N, Menezes C. Initial loss to follow up among tuberculosis patients: the role of Ward-Based Outreach Teams and short message service (SMS) technology (research proposal). BMC Res Notes 2019;12:737. [PMID: 31703722 DOI: 10.1186/s13104-019-4757-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Mwansa-Kambafwile JRM, Jewett S, Chasela C, Ismail N, Menezes C. Initial loss to follow up of tuberculosis patients in South Africa: perspectives of program managers. BMC Public Health 2020;20:622. [PMID: 32375743 DOI: 10.1186/s12889-020-08739-w] [Reference Citation Analysis]
4 Kendall EA, Azman AS, Maartens G, Boulle A, Wilkinson RJ, Dowdy DW, Rangaka MX. Projected population-wide impact of antiretroviral therapy-linked isoniazid preventive therapy in a high-burden setting. AIDS 2019;33:525-36. [PMID: 30325773 DOI: 10.1097/QAD.0000000000002053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Schumacher SG, Wells WA, Nicol MP, Steingart KR, Theron G, Dorman SE, Pai M, Churchyard G, Scott L, Stevens W, Nabeta P, Alland D, Weyer K, Denkinger CM, Gilpin C. Guidance for Studies Evaluating the Accuracy of Sputum-Based Tests to Diagnose Tuberculosis. J Infect Dis 2019;220:S99-S107. [PMID: 31593597 DOI: 10.1093/infdis/jiz258] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
6 Dowdy DW, Andrews JR, Dodd PJ, Gilman RH. A user-friendly, open-source tool to project impact and cost of diagnostic tests for tuberculosis. Elife 2014;3. [PMID: 24898755 DOI: 10.7554/eLife.02565] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
7 Vanqa N, Hoddinott G, Mbenyana B, Osman M, Meehan SA. Linkage to TB care: A qualitative study to understand linkage from the patients' perspective in the Western Cape Province, South Africa. PLoS One 2021;16:e0260200. [PMID: 34797855 DOI: 10.1371/journal.pone.0260200] [Reference Citation Analysis]
8 Squire SB, Thomson R, Namakhoma I, El Sony A, Kritski A, Madan J. Catastrophic care-seeking costs as an indicator for lung health. BMC Proc 2015;9:S4. [PMID: 28281702 DOI: 10.1186/1753-6561-9-S10-S4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
9 Nguyen LH, Codlin AJ, Vo LNQ, Dao T, Tran D, Forse RJ, Vu TN, Le GT, Luu T, Do GC, Truong VV, Minh HDT, Nguyen HH, Creswell J, Caws M, Nguyen HB, Nguyen NV. An Evaluation of Programmatic Community-Based Chest X-ray Screening for Tuberculosis in Ho Chi Minh City, Vietnam. Trop Med Infect Dis 2020;5:E185. [PMID: 33321696 DOI: 10.3390/tropicalmed5040185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Harries AD, Kumar AMV. Challenges and Progress with Diagnosing Pulmonary Tuberculosis in Low- and Middle-Income Countries. Diagnostics (Basel) 2018;8:E78. [PMID: 30477096 DOI: 10.3390/diagnostics8040078] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
11 Subbaraman R, Nathavitharana RR, Mayer KH, Satyanarayana S, Chadha VK, Arinaminpathy N, Pai M. Constructing care cascades for active tuberculosis: A strategy for program monitoring and identifying gaps in quality of care. PLoS Med 2019;16:e1002754. [PMID: 30811385 DOI: 10.1371/journal.pmed.1002754] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 13.0] [Reference Citation Analysis]
12 Chikhungu LC, Bispo S, Rollins N, Siegfried N, Newell ML. HIV-free survival at 12-24 months in breastfed infants of HIV-infected women on antiretroviral treatment. Trop Med Int Health 2016;21:820-8. [PMID: 27120500 DOI: 10.1111/tmi.12710] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
13 Maraba N, Hoffmann CJ, Chihota VN, Chang LW, Ismail N, Candy S, Madibogo E, Katzwinkel M, Churchyard GJ, McCarthy K. Using mHealth to improve tuberculosis case identification and treatment initiation in South Africa: Results from a pilot study. PLoS One 2018;13:e0199687. [PMID: 29969486 DOI: 10.1371/journal.pone.0199687] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
14 Sohn H, Tucker A, Ferguson O, Gomes I, Dowdy D. Costing the implementation of public health interventions in resource-limited settings: a conceptual framework. Implement Sci 2020;15:86. [PMID: 32993713 DOI: 10.1186/s13012-020-01047-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Dowdy DW, Grant AD, Dheda K, Nardell E, Fielding K, Moore DAJ. Designing and Evaluating Interventions to Halt the Transmission of Tuberculosis. J Infect Dis 2017;216:S654-61. [PMID: 29112743 DOI: 10.1093/infdis/jix320] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 3.6] [Reference Citation Analysis]
16 Lessells RJ, Cooke GS, McGrath N, Nicol MP, Newell ML, Godfrey-Faussett P. Impact of Point-of-Care Xpert MTB/RIF on Tuberculosis Treatment Initiation. A Cluster-randomized Trial. Am J Respir Crit Care Med 2017;196:901-10. [PMID: 28727491 DOI: 10.1164/rccm.201702-0278OC] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
17 Mac TH, Phan TH, Nguyen VV, Dong TTT, Le HV, Nguyen QD, Nguyen TD, Codlin AJ, Mai TDT, Forse RJ, Nguyen LP, Luu THT, Nguyen HB, Nguyen NV, Pham XT, Tran PN, Khan A, Vo LNQ, Creswell J. Optimizing Active Tuberculosis Case Finding: Evaluating the Impact of Community Referral for Chest X-ray Screening and Xpert Testing on Case Notifications in Two Cities in Viet Nam. Trop Med Infect Dis 2020;5:E181. [PMID: 33265972 DOI: 10.3390/tropicalmed5040181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zawedde-Muyanja S, Katamba A, Cattamanchi A, Castelnuovo B, Manabe YC. Patient and health system factors associated with pretreatment loss to follow up among patients diagnosed with tuberculosis using Xpert® MTB/RIF testing in Uganda. BMC Public Health 2020;20:1855. [PMID: 33272226 DOI: 10.1186/s12889-020-09955-0] [Reference Citation Analysis]
19 Kanakaraju M, Nagaraja SB, Satyanarayana S, Babu YR, Madhukeshwar AK, Narasimhaiah S. Chest Radiography and Xpert MTB/RIF® Testing in Persons with Presumptive Pulmonary TB: Gaps and Challenges from a District in Karnataka, India. Tuberc Res Treat 2020;2020:5632810. [PMID: 31969997 DOI: 10.1155/2020/5632810] [Reference Citation Analysis]
20 Harries AD, Kumar AMV, Satyanarayana S, Thekkur P, Lin Y, Dlodlo RA, Zachariah R. How Can Operational Research Help to Eliminate Tuberculosis in the Asia Pacific Region? Trop Med Infect Dis 2019;4:E47. [PMID: 30875884 DOI: 10.3390/tropicalmed4010047] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
21 Tollefson D, Ngari F, Mwakala M, Gethi D, Kipruto H, Cain K, Bloss E. Under-reporting of sputum smear-positive tuberculosis cases in Kenya. Int J Tuberc Lung Dis 2016;20:1334-41. [PMID: 27725044 DOI: 10.5588/ijtld.16.0156] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
22 Frank M, Adamashvili N, Lomtadze N, Kokhreidze E, Avaliani Z, Kempker RR, Blumberg HM. Long-term Follow-up Reveals High Posttreatment Mortality Rate Among Patients With Extensively Drug-Resistant Tuberculosis in the Country of Georgia. Open Forum Infect Dis 2019;6:ofz152. [PMID: 31041349 DOI: 10.1093/ofid/ofz152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Datta S, Shah L, Gilman RH, Evans CA. Comparison of sputum collection methods for tuberculosis diagnosis: a systematic review and pairwise and network meta-analysis. Lancet Glob Health 2017;5:e760-71. [PMID: 28625793 DOI: 10.1016/S2214-109X(17)30201-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 17] [Article Influence: 6.8] [Reference Citation Analysis]
24 Chilembo M, Oguri S, Matsuoka Y, Ota M, Musiankuni P, Kabungo J. Pre-treatment lost to follow-up tuberculosis patients, Chongwe, Zambia, 2017: a retrospective cohort study. Public Health Action 2020;10:21-6. [PMID: 32368520 DOI: 10.5588/pha.19.0059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Codlin AJ, Monyrath C, Ky M, Gerstel L, Creswell J, Eang MT. Results from a roving, active case finding initiative to improve tuberculosis detection among older people in rural cambodia using the Xpert MTB/RIF assay and chest X-ray. J Clin Tuberc Other Mycobact Dis 2018;13:22-7. [PMID: 31720408 DOI: 10.1016/j.jctube.2018.11.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
26 Evans D, Sineke T, Schnippel K, Berhanu R, Govathson C, Black A, Long L, Rosen S. Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa. BMC Health Serv Res 2018;18:973. [PMID: 30558670 DOI: 10.1186/s12913-018-3762-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
27 Der JB, Grint D, Narh CT, Bonsu F, Grant AD. Where are patients missed in the tuberculosis diagnostic cascade? A prospective cohort study in Ghana. PLoS One 2020;15:e0230604. [PMID: 32191768 DOI: 10.1371/journal.pone.0230604] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Salvatore PP, Kendall EA, Seabrook D, Brown J, Durham GH, Dowdy DW. Projecting the impact of variable MDR-TB transmission efficiency on long-term epidemic trends in South Africa and Vietnam. Sci Rep 2019;9:18099. [PMID: 31792289 DOI: 10.1038/s41598-019-54561-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
29 Bassett IV, Coleman SM, Giddy J, Bogart LM, Chaisson CE, Ross D, Flash MJ, Govender T, Walensky RP, Freedberg KA, Losina E. Barriers to Care and 1-Year Mortality Among Newly Diagnosed HIV-Infected People in Durban, South Africa. J Acquir Immune Defic Syndr 2017;74:432-8. [PMID: 28060226 DOI: 10.1097/QAI.0000000000001277] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
30 Mhalu G, Weiss MG, Hella J, Mhimbira F, Mahongo E, Schindler C, Reither K, Fenner L, Zemp E, Merten S. Explaining patient delay in healthcare seeking and loss to diagnostic follow-up among patients with presumptive tuberculosis in Tanzania: a mixed-methods study. BMC Health Serv Res 2019;19:217. [PMID: 30953502 DOI: 10.1186/s12913-019-4030-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
31 Telisinghe L, Ruperez M, Amofa-Sekyi M, Mwenge L, Mainga T, Kumar R, Hassan M, Chaisson LH, Naufal F, Shapiro AE, Golub JE, Miller C, Corbett EL, Burke RM, MacPherson P, Hayes RJ, Bond V, Daneshvar C, Klinkenberg E, Ayles HM. Does tuberculosis screening improve individual outcomes? A systematic review. EClinicalMedicine 2021;40:101127. [PMID: 34604724 DOI: 10.1016/j.eclinm.2021.101127] [Reference Citation Analysis]
32 Little KM, Pai M, Dowdy DW. Costs and Consequences of Using Interferon-γ Release Assays for the Diagnosis of Active Tuberculosis in India. PLoS One 2014;10:e0124525. [PMID: 25918999 DOI: 10.1371/journal.pone.0124525] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
33 Sanaie A, Mergenthaler C, Nasrat A, Seddiq MK, Mahmoodi SD, Stevens RH, Creswell J. An Evaluation of Passive and Active Approaches to Improve Tuberculosis Notifications in Afghanistan. PLoS One 2016;11:e0163813. [PMID: 27701446 DOI: 10.1371/journal.pone.0163813] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
34 Sohn H, Kasaie P, Kendall E, Gomez GB, Vassall A, Pai M, Dowdy D. Informing decision-making for universal access to quality tuberculosis diagnosis in India: an economic-epidemiological model. BMC Med 2019;17:155. [PMID: 31382959 DOI: 10.1186/s12916-019-1384-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
35 Osman M, Meehan SA, von Delft A, Du Preez K, Dunbar R, Marx FM, Boulle A, Welte A, Naidoo P, Hesseling AC. Early mortality in tuberculosis patients initially lost to follow up following diagnosis in provincial hospitals and primary health care facilities in Western Cape, South Africa. PLoS One 2021;16:e0252084. [PMID: 34125843 DOI: 10.1371/journal.pone.0252084] [Reference Citation Analysis]
36 Sumner T, Bozzani F, Mudzengi D, Hippner P, Houben RM, Cardenas V, Vassall A, White RG. Estimating the Impact of Tuberculosis Case Detection in Constrained Health Systems: An Example of Case-Finding in South Africa. Am J Epidemiol 2019;188:1155-64. [PMID: 30824911 DOI: 10.1093/aje/kwz038] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
37 Hussain H, Malik A, Ahmed JF, Siddiqui S, Amanullah F, Creswell J, Tylleskär T, Robberstad B. Cost-effectiveness of household contact investigation for detection of tuberculosis in Pakistan. BMJ Open 2021;11:e049658. [PMID: 34686551 DOI: 10.1136/bmjopen-2021-049658] [Reference Citation Analysis]
38 Kibuule D, Aiases P, Ruswa N, Rennie TW, Verbeeck RK, Godman B, Mubita M. Predictors of loss to follow-up of tuberculosis cases under the DOTS programme in Namibia. ERJ Open Res 2020;6:00030-2019. [PMID: 32201689 DOI: 10.1183/23120541.00030-2019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
39 Feasey HRA, Corbett EL, Nliwasa M, Mair L, Divala TH, Kamchedzera W, Khundi ME, Burchett HED, Webb EL, Maheswaran H, Squire SB, MacPherson P. Tuberculosis diagnosis cascade in Blantyre, Malawi: a prospective cohort study. BMC Infect Dis 2021;21:178. [PMID: 33588804 DOI: 10.1186/s12879-021-05860-y] [Reference Citation Analysis]
40 Kapata N, Grobusch MP, Chongwe G, Chanda-Kapata P, Ngosa W, Tembo M, Musonda S, Katemangwe P, Bates M, Mwaba P, Zumla A, Cobelens F. Outcomes of multidrug-resistant tuberculosis in Zambia: a cohort analysis. Infection 2017;45:831-9. [PMID: 28779436 DOI: 10.1007/s15010-017-1054-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
41 Nliwasa M, MacPherson P, Chisala P, Kamdolozi M, Khundi M, Kaswaswa K, Mwapasa M, Msefula C, Sohn H, Flach C, Corbett EL. The Sensitivity and Specificity of Loop-Mediated Isothermal Amplification (LAMP) Assay for Tuberculosis Diagnosis in Adults with Chronic Cough in Malawi. PLoS One 2016;11:e0155101. [PMID: 27171380 DOI: 10.1371/journal.pone.0155101] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
42 Chawla KS, Kanyama C, Mbewe A, Matoga M, Hoffman I, Ngoma J, Hosseinipour MC. Policy to practice: impact of GeneXpert MTB/RIF implementation on the TB spectrum of care in Lilongwe, Malawi. Trans R Soc Trop Med Hyg 2016;110:305-11. [PMID: 27198215 DOI: 10.1093/trstmh/trw030] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
43 Mitchell EMH, Adejumo OA, Abdur-Razzaq H, Ogbudebe C, Chukwueme N, Olorunju SB, Gidado M. Hybrid Approach to Estimation of Underreporting of Tuberculosis Case Notification in High-Burden Settings With Weak Surveillance Infrastructure: Design and Implementation of an Inventory Study. JMIR Public Health Surveill 2021;7:e22352. [PMID: 33720030 DOI: 10.2196/22352] [Reference Citation Analysis]
44 Mundra A, Deshmukh PR, Dawale A. Magnitude and determinants of adverse treatment outcomes among tuberculosis patients registered under Revised National Tuberculosis Control Program in a Tuberculosis Unit, Wardha, Central India: A record-based cohort study. J Epidemiol Glob Health 2017;7:111-8. [PMID: 28315657 DOI: 10.1016/j.jegh.2017.02.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
45 Shete PB, Nalugwa T, Farr K, Ojok C, Nantale M, Howlett P, Haguma P, Ochom E, Mugabe F, Joloba M, Chaisson LH, Dowdy DW, Moore D, Davis JL, Katamba A, Cattamanchi A. Feasibility of a streamlined tuberculosis diagnosis and treatment initiation strategy. Int J Tuberc Lung Dis 2017;21:746-52. [PMID: 28633698 DOI: 10.5588/ijtld.16.0699] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
46 Vo LNQ, Codlin A, Ngo TD, Dao TP, Dong TTT, Mo HTL, Forse R, Nguyen TT, Cung CV, Nguyen HB, Nguyen NV, Nguyen VV, Tran NT, Nguyen GH, Qin ZZ, Creswell J. Early Evaluation of an Ultra-Portable X-ray System for Tuberculosis Active Case Finding. Trop Med Infect Dis 2021;6:163. [PMID: 34564547 DOI: 10.3390/tropicalmed6030163] [Reference Citation Analysis]
47 Skinner D, Claassens M. It's complicated: why do tuberculosis patients not initiate or stay adherent to treatment? A qualitative study from South Africa. BMC Infect Dis 2016;16:712. [PMID: 27887646 DOI: 10.1186/s12879-016-2054-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
48 Kendall EA, Azman AS, Cobelens FG, Dowdy DW. MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis. PLoS One 2017;12:e0172748. [PMID: 28273116 DOI: 10.1371/journal.pone.0172748] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
49 Harries AD, Lin Y, Kumar AMV, Satyanarayana S, Takarinda KC, Dlodlo RA, Zachariah R, Olliaro P. What can National TB Control Programmes in low- and middle-income countries do to end tuberculosis by 2030? F1000Res 2018;7:F1000 Faculty Rev-1011. [PMID: 30026917 DOI: 10.12688/f1000research.14821.1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
50 MacPherson P, Webb EL, Lalloo DG, Nliwasa M, Maheswaran H, Joekes E, Phiri D, Squire B, Pai M, Corbett EL. Design and protocol for a pragmatic randomised study to optimise screening, prevention and care for tuberculosis and HIV in Malawi (PROSPECT Study). Wellcome Open Res 2018;3:61. [PMID: 30542662 DOI: 10.12688/wellcomeopenres.14598.3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
51 Yuldashev S, Parpieva N, Alimov S, Turaev L, Safaev K, Dumchev K, Gadoev J, Korotych O, Harries AD. Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012-2019: Are We on the Right Track? Int J Environ Res Public Health 2021;18:4685. [PMID: 33924862 DOI: 10.3390/ijerph18094685] [Reference Citation Analysis]
52 Ali SM, Naureen F, Noor A, Fatima I, Viney K, Ishaq M, Anjum N, Rashid A, Haider GR, Khan MA, Aamir J. Loss-to-follow-up and delay to treatment initiation in Pakistan's national tuberculosis control programme. BMC Public Health 2018;18:335. [PMID: 29523100 DOI: 10.1186/s12889-018-5222-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
53 Hossain ST, Isaakidis P, Sagili KD, Islam S, Islam MA, Shewade HD, Kamal SM, Husain A. The Multi-Drug Resistant Tuberculosis Diagnosis and Treatment Cascade in Bangladesh. PLoS One 2015;10:e0129155. [PMID: 26110273 DOI: 10.1371/journal.pone.0129155] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
54 Vo LNQ, Codlin AJ, Forse RJ, Nguyen NT, Vu TN, Le GT, Van Truong V, Do GC, Dang HM, Nguyen LH, Nguyen HB, Nguyen NV, Levy J, Lonnroth K, Squire SB, Caws M. Evaluating the yield of systematic screening for tuberculosis among three priority groups in Ho Chi Minh City, Viet Nam. Infect Dis Poverty 2020;9:166. [PMID: 33292638 DOI: 10.1186/s40249-020-00766-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Harries AD, Kumar AMV, Satyanarayana S, Thekkur P, Lin Y, Dlodlo RA, Khogali M, Zachariah R. The Growing Importance of Tuberculosis Preventive Therapy and How Research and Innovation Can Enhance Its Implementation on the Ground. Trop Med Infect Dis 2020;5:E61. [PMID: 32316300 DOI: 10.3390/tropicalmed5020061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
56 Datta S, Alvarado K, Gilman RH, Valencia T, Aparicio C, Ramos ES, Montoya R, Evans CA. Optimising fluorescein diacetate sputum smear microscopy for assessing patients with pulmonary tuberculosis. PLoS One 2019;14:e0214131. [PMID: 31039160 DOI: 10.1371/journal.pone.0214131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
57 Mailu EW, Owiti P, Ade S, Harries AD, Manzi M, Omesa E, Kiende P, Macharia S, Mbithi I, Kamene M. Tuberculosis control activities in the private and public health sectors of Kenya from 2013 to 2017: how do they compare? Trans R Soc Trop Med Hyg 2019;113:740-8. [PMID: 31334760 DOI: 10.1093/trstmh/trz062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
58 Haraka F, Kakolwa M, Schumacher SG, Nathavitharana RR, Denkinger CM, Gagneux S, Reither K, Ross A. Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis. Cochrane Database Syst Rev 2021;5:CD012972. [PMID: 34097769 DOI: 10.1002/14651858.CD012972.pub2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
59 Thomas BE, Suresh C, Lavanya J, Lindsley MM, Galivanche AT, Sellappan S, Ovung S, Aravind A, Lincy S, Raja AL, Kokila S, Javeed B, Arumugam S, Mayer KH, Swaminathan S, Subbaraman R. Understanding pretreatment loss to follow-up of tuberculosis patients: an explanatory qualitative study in Chennai, India. BMJ Glob Health 2020;5:e001974. [PMID: 32181000 DOI: 10.1136/bmjgh-2019-001974] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
60 Venter R, Derendinger B, de Vos M, Pillay S, Dolby T, Simpson J, Kitchin N, Ruiters A, van Helden PD, Warren RM, Theron G. Mycobacterial genomic DNA from used Xpert MTB/RIF cartridges can be utilised for accurate second-line genotypic drug susceptibility testing and spoligotyping. Sci Rep 2017;7:14854. [PMID: 29093504 DOI: 10.1038/s41598-017-14385-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
61 Desalegn DM, Kitila KT, Taddese BD, Hailu TK, Dinku TT, Asferie KD, Balcha HM, Gebeyehu CS, Medhin G. Sputum Smear Positive Pulmonary Tuberculosis Diagnostic Dropout Rate in Public Health Facilities, Addis Ababa, Ethiopia. Pulm Med 2019;2019:2905615. [PMID: 31016044 DOI: 10.1155/2019/2905615] [Reference Citation Analysis]
62 Padingani M, Kumar A, Tripathy JP, Masuka N, Khumalo S. Does pre-diagnostic loss to follow-up among presumptive TB patients differ by type of health facility? An operational research from Hwange, Zimbabwe in 2017. Pan Afr Med J 2018;31:196. [PMID: 31086640 DOI: 10.11604/pamj.2018.31.196.15848] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
63 Horton KC, MacPherson P, Houben RM, White RG, Corbett EL. Sex Differences in Tuberculosis Burden and Notifications in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis. PLoS Med 2016;13:e1002119. [PMID: 27598345 DOI: 10.1371/journal.pmed.1002119] [Cited by in Crossref: 128] [Cited by in F6Publishing: 114] [Article Influence: 21.3] [Reference Citation Analysis]
64 Arora R, Khanna A, Sharma N, Khanna V, Shringarpure K, Kathirvel S. Early implementation challenges in electronic referral and feedback mechanism for patients with tuberculosis using Nikshay - A mixed-methods study from a medical college TB referral unit of Delhi, India. J Family Med Prim Care 2021;10:1678-86. [PMID: 34123912 DOI: 10.4103/jfmpc.jfmpc_1360_20] [Reference Citation Analysis]
65 Pearlman SI, Tang EM, Tao YK, Haselton FR. Controlling Droplet Marangoni Flows to Improve Microscopy-Based TB Diagnosis. Diagnostics (Basel) 2021;11:2155. [PMID: 34829502 DOI: 10.3390/diagnostics11112155] [Reference Citation Analysis]
66 Di Tanna GL, Khaki AR, Theron G, McCarthy K, Cox H, Mupfumi L, Trajman A, Zijenah LS, Mason P, Bandason T, Durovni B, Bara W, Hoelscher M, Clowes P, Mangu C, Chanda D, Pym A, Mwaba P, Cobelens F, Nicol MP, Dheda K, Churchyard G, Fielding K, Metcalfe JZ. Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis. Lancet Glob Health 2019;7:e191-9. [PMID: 30683238 DOI: 10.1016/S2214-109X(18)30458-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 13.5] [Reference Citation Analysis]
67 Kruk ME, Gage AD, Arsenault C, Jordan K, Leslie HH, Roder-DeWan S, Adeyi O, Barker P, Daelmans B, Doubova SV, English M, García-Elorrio E, Guanais F, Gureje O, Hirschhorn LR, Jiang L, Kelley E, Lemango ET, Liljestrand J, Malata A, Marchant T, Matsoso MP, Meara JG, Mohanan M, Ndiaye Y, Norheim OF, Reddy KS, Rowe AK, Salomon JA, Thapa G, Twum-Danso NAY, Pate M. High-quality health systems in the Sustainable Development Goals era: time for a revolution. Lancet Glob Health 2018;6:e1196-252. [PMID: 30196093 DOI: 10.1016/S2214-109X(18)30386-3] [Cited by in Crossref: 636] [Cited by in F6Publishing: 421] [Article Influence: 159.0] [Reference Citation Analysis]
68 Vo LNQ, Forse RJ, Codlin AJ, Vu TN, Le GT, Do GC, Van Truong V, Dang HM, Nguyen LH, Nguyen HB, Nguyen NV, Levy J, Squire B, Lonnroth K, Caws M. A comparative impact evaluation of two human resource models for community-based active tuberculosis case finding in Ho Chi Minh City, Viet Nam. BMC Public Health 2020;20:934. [PMID: 32539700 DOI: 10.1186/s12889-020-09042-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
69 Sengai T, Timire C, Harries AD, Tweya H, Kavenga F, Shumba G, Tavengerwei J, Ncube R, Zishiri C, Mapfurira MJ, Mandizvidza V, Sandy C. Mobile targeted screening for tuberculosis in Zimbabwe: diagnosis, linkage to care and treatment outcomes. Public Health Action 2019;9:159-65. [PMID: 32042608 DOI: 10.5588/pha.19.0040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
70 Ismail IM, Kibballi Madhukeshwar A, Naik PR, Nayarmoole BM, Satyanarayana S. Magnitude and Reasons for Gaps in Tuberculosis Diagnostic Testing and Treatment Initiation: An Operational Research Study from Dakshina Kannada, South India. J Epidemiol Glob Health 2020;10:326-36. [PMID: 32959619 DOI: 10.2991/jegh.k.200516.001] [Reference Citation Analysis]
71 Yende-Zuma N, Naidoo K. The Effect of Timing of Initiation of Antiretroviral Therapy on Loss to Follow-up in HIV-Tuberculosis Coinfected Patients in South Africa: An Open-Label, Randomized, Controlled Trial. J Acquir Immune Defic Syndr 2016;72:430-6. [PMID: 26990824 DOI: 10.1097/QAI.0000000000000995] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
72 Sulis G, Pai M. Missing tuberculosis patients in the private sector: business as usual will not deliver results. Public Health Action 2017;7:80-1. [PMID: 28695077 DOI: 10.5588/pha.17.0039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
73 Mwansa-Kambafwile J, Maitshotlo B, Black A. Microbiologically Confirmed Tuberculosis: Factors Associated with Pre-Treatment Loss to Follow-Up, and Time to Treatment Initiation. PLoS One 2017;12:e0168659. [PMID: 28068347 DOI: 10.1371/journal.pone.0168659] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
74 Debes AK, Gilman RH, Onyango-Makumbi C, Ruff A, Oberhelman R, Dowdy DW. Cost-effectiveness of Diagnostic Algorithms for Tuberculosis in Children Less Than 5 Years of Age. Pediatr Infect Dis J 2017;36:36-43. [PMID: 27749648 DOI: 10.1097/INF.0000000000001342] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
75 Htwe KK, Kyaw NTT, Kumar AMV, Kyaw KWY, Oo MM, Thwin T, Saw S, Aung ST. Pre-treatment loss to follow-up and treatment delay among bacteriologically-confirmed tuberculosis patients diagnosed in Mandalay Region, Myanmar. Trop Med Health 2019;47:30. [PMID: 31073273 DOI: 10.1186/s41182-019-0154-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
76 Subbaraman R, Jhaveri T, Nathavitharana RR. Closing gaps in the tuberculosis care cascade: an action-oriented research agenda. J Clin Tuberc Other Mycobact Dis 2020;19:100144. [PMID: 32072022 DOI: 10.1016/j.jctube.2020.100144] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
77 Sodeng K, Botu A, Semmie M, Yoannes M, Shewade HD, Commons R, Graham SM, du Cros P. Challenges in TB diagnosis and treatment: the Kavieng Provincial Hospital experience, Papua New Guinea. Public Health Action 2019;9:S57-61. [PMID: 31579651 DOI: 10.5588/pha.18.0066] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
78 Lawn SD. Advances in Diagnostic Assays for Tuberculosis. Cold Spring Harb Perspect Med 2015;5:a017806. [PMID: 26253092 DOI: 10.1101/cshperspect.a017806] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
79 Cilloni L, Kranzer K, Stagg HR, Arinaminpathy N. Trade-offs between cost and accuracy in active case finding for tuberculosis: A dynamic modelling analysis. PLoS Med 2020;17:e1003456. [PMID: 33264288 DOI: 10.1371/journal.pmed.1003456] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
80 Sullivan BJ, Esmaili BE, Cunningham CK. Barriers to initiating tuberculosis treatment in sub-Saharan Africa: a systematic review focused on children and youth. Glob Health Action 2017;10:1290317. [PMID: 28598771 DOI: 10.1080/16549716.2017.1290317] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
81 Choun K, Decroo T, Mao TE, Lorent N, Gerstel L, Creswell J, Codlin AJ, Lynen L, Thai S. Performance of algorithms for tuberculosis active case finding in underserved high-prevalence settings in Cambodia: a cross-sectional study. Glob Health Action 2019;12:1646024. [PMID: 31500551 DOI: 10.1080/16549716.2019.1646024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
82 Warner DF, Mizrahi V. Translating genomics research into control of tuberculosis: lessons learned and future prospects. Genome Biol 2014;15:514. [PMID: 25408168 DOI: 10.1186/s13059-014-0514-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
83 Baik Y, Rickman HM, Hanrahan CF, Mmolawa L, Kitonsa PJ, Sewelana T, Nalutaaya A, Kendall EA, Lebina L, Martinson N, Katamba A, Dowdy DW. A clinical score for identifying active tuberculosis while awaiting microbiological results: Development and validation of a multivariable prediction model in sub-Saharan Africa. PLoS Med 2020;17:e1003420. [PMID: 33170838 DOI: 10.1371/journal.pmed.1003420] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
84 Zawedde-Muyanja S, Musaazi J, Manabe YC, Katamba A, Nankabirwa JI, Castelnuovo B, Cattamanchi A. Estimating the effect of pretreatment loss to follow up on TB associated mortality at public health facilities in Uganda. PLoS One 2020;15:e0241611. [PMID: 33206650 DOI: 10.1371/journal.pone.0241611] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
85 Kerschberger B, Schomaker M, Telnov A, Vambe D, Kisyeri N, Sikhondze W, Pasipamire L, Ngwenya SM, Rusch B, Ciglenecki I, Boulle A. Decreased risk of HIV-associated TB during antiretroviral therapy expansion in rural Eswatini from 2009 to 2016: a cohort and population-based analysis. Trop Med Int Health 2019;24:1114-27. [PMID: 31310029 DOI: 10.1111/tmi.13290] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
86 Evans D, Schnippel K, Govathson C, Sineke T, Black A, Long L, Berhanu R, Rosen S. Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa. PLoS One 2017;12:e0181238. [PMID: 28746344 DOI: 10.1371/journal.pone.0181238] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
87 Stagg HR, Flook M, Martinecz A, Kielmann K, Abel Zur Wiesch P, Karat AS, Lipman MCI, Sloan DJ, Walker EF, Fielding KL. All nonadherence is equal but is some more equal than others? Tuberculosis in the digital era. ERJ Open Res 2020;6:00315-2020. [PMID: 33263043 DOI: 10.1183/23120541.00315-2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
88 Umo I, Kulai M, Commons RJ. Factors associated with loss to follow-up among TB patients in rural Papua New Guinea. Public Health Action 2021;11:186-90. [PMID: 34956846 DOI: 10.5588/pha.21.0054] [Reference Citation Analysis]
89 Bassett IV, Coleman SM, Giddy J, Bogart LM, Chaisson CE, Ross D, Jacobsen MM, Robine M, Govender T, Freedberg KA, Katz JN, Walensky RP, Losina E. Sizanani: A Randomized Trial of Health System Navigators to Improve Linkage to HIV and TB Care in South Africa. J Acquir Immune Defic Syndr 2016;73:154-60. [PMID: 27632145 DOI: 10.1097/QAI.0000000000001025] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
90 Ku CC, MacPherson P, Khundi M, Nzawa Soko RH, Feasey HRA, Nliwasa M, Horton KC, Corbett EL, Dodd PJ. Durations of asymptomatic, symptomatic, and care-seeking phases of tuberculosis disease with a Bayesian analysis of prevalence survey and notification data. BMC Med 2021;19:298. [PMID: 34753468 DOI: 10.1186/s12916-021-02128-9] [Reference Citation Analysis]
91 Gupta-Wright A, Manabe YC. Implementation science: point-of-care diagnostics in HIV and tuberculosis. Clin Med (Lond) 2019;19:145-8. [PMID: 30872299 DOI: 10.7861/clinmedicine.19-2-145] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
92 Pardeshi G, Deluca A, Agarwal S, Kishore J. Tuberculosis patients not covered by treatment in public health services: findings from India's National Family Health Survey 2015-16. Trop Med Int Health 2018;23:886-95. [PMID: 29851437 DOI: 10.1111/tmi.13086] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
93 Nirgude AS, Kumar AMV, Collins T, Naik PR, Parmar M, Tao L, Akshaya KM, Raghuveer P, Yatnatti SK, Nagendra N, Nagaraja SB, Habeena S, Mn B, Rao R, Shastri S. 'I am on treatment since 5 months but I have not received any money': coverage, delays and implementation challenges of 'Direct Benefit Transfer' for tuberculosis patients - a mixed-methods study from South India. Glob Health Action 2019;12:1633725. [PMID: 31328678 DOI: 10.1080/16549716.2019.1633725] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
94 Peterson I, Ntsui N, Jambo K, Kelly C, Huwa J, Afran L, Tatuene JK, Pett S, Henrion MYR, Van Oosterhout J, Heyderman RS, Mwandumba H, Benjamin LA; Investigators of the RHICCA study. Evaluating the reactivation of herpesviruses and inflammation as cardiovascular and cerebrovascular risk factors in antiretroviral therapy initiators in an African HIV-infected population (RHICCA): a protocol for a longitudinal cohort study. BMJ Open 2019;9:e025576. [PMID: 31515413 DOI: 10.1136/bmjopen-2018-025576] [Reference Citation Analysis]
95 Subbaraman R, Thomas BE, Sellappan S, Suresh C, Jayabal L, Lincy S, Raja AL, McFall A, Solomon SS, Mayer KH, Swaminathan S. Tuberculosis patients in an Indian mega-city: Where do they live and where are they diagnosed? PLoS One 2017;12:e0183240. [PMID: 28813536 DOI: 10.1371/journal.pone.0183240] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
96 Van Der Elst EM, Kombo B, Mugo P, Thiong'o A, Kanungi J, Wahome E, Chirro O, Graham SM, Operario D, Sanders EJ. Adjustment to acute or early HIV-1 infection diagnosis to prompt linkage to care and ART initiation: qualitative insights from coastal Kenya. Psychol Health Med 2019;24:631-41. [PMID: 30468392 DOI: 10.1080/13548506.2018.1549736] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
97 Oo T, Kyaw KWY, Soe KT, Saw S, Satyanarayana S, Aung ST. Magnitude and reasons for pre-diagnosis attrition among presumptive multi-drug resistant tuberculosis patients in Bago Region, Myanmar: A mixed methods study. Sci Rep 2019;9:7189. [PMID: 31076579 DOI: 10.1038/s41598-019-43562-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
98 Wagstaff A, van Doorslaer E, Burger R. SMS nudges as a tool to reduce tuberculosis treatment delay and pretreatment loss to follow-up. A randomized controlled trial. PLoS One 2019;14:e0218527. [PMID: 31220140 DOI: 10.1371/journal.pone.0218527] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
99 Hippner P, Sumner T, Houben RM, Cardenas V, Vassall A, Bozzani F, Mudzengi D, Mvusi L, Churchyard G, White RG. Application of provincial data in mathematical modelling to inform sub-national tuberculosis program decision-making in South Africa. PLoS One 2019;14:e0209320. [PMID: 30682028 DOI: 10.1371/journal.pone.0209320] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
100 MacPherson P, Webb EL, Variava E, Lala SG, Milovanovic M, Ratsela A, Lebina L, Kinghorn A, Martinson NA. Intensified household contact tracing, prevention and treatment support versus enhanced standard of care for contacts of tuberculosis cases in South Africa: study protocol for a household cluster-randomised trial. BMC Infect Dis 2019;19:839. [PMID: 31606032 DOI: 10.1186/s12879-019-4502-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
101 Babirye D, Shete PB, Farr K, Nalugwa T, Ojok C, Nantale M, Oyuku D, Ayakaka I, Katamba A, Davis JL, Nadunga D, Joloba M, Moore D, Cattamanchi A. Feasibility of a short message service (SMS) intervention to deliver tuberculosis testing results in peri-urban and rural Uganda. J Clin Tuberc Other Mycobact Dis 2019;16:100110. [PMID: 31720434 DOI: 10.1016/j.jctube.2019.100110] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
102 Wali A, Kumar AMV, Hinderaker SG, Heldal E, Qadeer E, Fatima R, Ullah A, Safdar N, Yaqoob A, Anwar K, Ul Haq M. Pre-treatment loss to follow-up among smear-positive TB patients in tertiary hospitals, Quetta, Pakistan. Public Health Action 2017;7:21-5. [PMID: 28775939 DOI: 10.5588/pha.16.0118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
103 Secretary Of Jan Swasthya Sahyog, Laux TS, Patil S. Predictors of tuberculosis treatment outcomes among a retrospective cohort in rural, Central India. J Clin Tuberc Other Mycobact Dis 2018;12:41-7. [PMID: 31720398 DOI: 10.1016/j.jctube.2018.06.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]